HERCEPTIN 'CUTS RISK' OF CANCER
9th Dec 2005, 07:55 GMT
THE controversial drug Herceptin cuts the risk of early stage aggressive breast cancer returning after treatment by up to 51 per cent, a study published today reveals.
HERCEPTIN 'CUTS RISK' OF CANCER related news:
- Breast cancer drug halves return risk — the Mail online | Health
- Chemo regimen can limit Herceptin heart risk-study (Reuters) — Yahoo! News: Health News
- Chemo regimen can limit Herceptin heart risk-study — Reuters: Health
- Herceptin proving to be a wonder drug — The Cardio Blog
- Drug for cancer is successful — Scotsman.com News - Breast cancer
- Herceptin OK as upfront cancer drug — United Press International - Health Business
- Combining herceptin with chemotherapy improves survival in breast cancer — KeralaNext: Health
- Breast cancer drug 'halves risk' — the Mail online | Health news
- Herceptin promising in early breast cancer — United Press International - Health Business
- Interim Analysis of Phase III Study Shows TAXOTERE Based Regimens With HERCEPTIN Significantly Improved Disease Free Survival in Women With Early-Stage HER2-Positive Breast Cancer — Mammography News from StratCenter.com
Latest news from Mirror.co.uk - News - Top Stories:
- THE POPPY DAY MASSACRE
- EXCLUSIVE: HAMMOND: I FEEL LIKE ME AGAIN
- BLAIR IN NEW PEACE PLAN BID
- THE BOATLESS BOOZE CRUISE
- POLICE ASK MINISTERS TO DENY LINKS
- IRAQ WAR MUM IN POPPY DAY PRIDE
- EXCLUSIVE: TROOPS' TENSE SILENCE
- EXCLUSIVE: JUDE & SIENNA SPLIT FOR GOOD
- TO SIR WITH HATE
- FED-EX'S BRIEFS TRIP TO SHOPS